Related Experiment Videos

The use of prophylactic fluconazole in immunocompetent high-risk surgical patients: a meta-analysis

Kwok M Ho1, Jeffrey Lipman, Geoffrey J Dobb

  • 1Department of Intensive Care, Royal Perth Hospital, Australia. kwok.ho@health.wa.gov.au

Abstract

Insights

Prophylactic fluconazole significantly reduced candidaemia in high-risk surgical patients. While it showed a trend towards lower hospital mortality, this was not statistically significant.

Area of Science:

  • Infectious Diseases
  • Surgical Critical Care
  • Pharmacology

Background:

  • High-risk surgical patients face elevated risks of fungal infections and candidaemia.
  • Previous studies suggest prophylactic fluconazole may decrease fungal infections and mortality.
  • This study specifically examines immunocompetent patients undergoing surgery.

Purpose of the Study:

  • To evaluate the efficacy of prophylactic fluconazole in reducing candidaemia incidence.
  • To assess the impact of prophylactic fluconazole on hospital mortality in high-risk surgical patients.
  • To analyze the effect on other fungal infections and the need for rescue therapies.

Main Methods:

  • Systematic review and meta-analysis of randomized controlled trials.
  • Inclusion of studies on immunocompetent high-risk surgical patients receiving fluconazole.
  • Data extraction and quality assessment performed independently by two reviewers.

Main Results:

  • Prophylactic fluconazole reduced candidaemia (RR=0.21) and non-urinary tract fungal infections (RR=0.39).
  • A trend towards reduced hospital mortality was observed (RR=0.82), but not statistically significant (P=0.15).
  • Reduced need for systemic amphotericin B rescue therapy was noted (RR=0.35).

Conclusions:

  • Prophylactic fluconazole effectively lowers the incidence of candidaemia in immunocompetent high-risk surgical patients.
  • A trend towards reduced hospital mortality exists, warranting further investigation.
  • No significant increase in fluconazole-resistant fungal infections was observed.

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...